PG
Therapeutic Areas
180 Life Sciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Anti-TNF (Local Administration) | Dupuytren's Disease (Early Stage) | Phase 2b |
| Synthetic Cannabinoid Analogs | Chronic Pain & Inflammation | Pre-clinical |
| α7nAChR Program | Inflammatory Bowel Disease (IBD) & Other Inflammatory Conditions | Pre-clinical |
Leadership Team at 180 Life Sciences
DJ
Dr. James N. Woody
Chief Executive Officer & Director
DL
Dr. Lawrence Steinman
Chairman of the Scientific Advisory Board & Co-Founder
PS
Prof. Sir Marc Feldmann
Scientific Advisory Board & Co-Founder
PJ
Prof. Jagdeep Nanchahal
Scientific Advisory Board & Co-Founder
CM
Catherine M. Vaczy
Chief Strategy Officer & General Counsel
OP
Ozan Pamir
Interim Chief Financial Officer
DJ
Dr. Jonathan Rothbard
Chief Scientific Officer
DJ
Dr. John A. L. Meldrum
Board Director
KJ
Kevin J. Connors
Board Director